Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV
Endocrine Reviews · 04.03.2024 · 45 (2) · 190-209
DOI: 10.1210/endrev/bnad028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 09.08.2023. Verfasst von Claudia E Ramirez Bustamante und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Over the past 4 decades, the clinical care of people living with HIV (PLWH) evolved from treatment of acute opportunistic infections to the management of chronic, noncommunicable comorbidities. Concurrently, our understanding of adipose tissue function matured to acknowledge its important endocrine contributions to energy balance. PLWH experience changes in the mass and composition of adipose tissue depots before and after initiating antiretroviral therapy, including regional loss (lipoatrophy), gain (lipohypertrophy), or mixed lipodystrophy. These conditions may coexist with generalized obesity in PLWH and reflect disturbances of energy balance regulation caused by HIV persistence and antiretroviral therapy drugs. Adipocyte hypertrophy characterizes visceral and subcutaneous adipose tissue depot expansion, as well as ectopic lipid deposition that occurs diffusely in the liver, skeletal muscle, and heart. PLWH with excess visceral adipose tissue exhibit adipokine dysregulation coupled with increased insulin resistance, heightening their risk for cardiovascular disease above that of the HIV-negative population. However, conventional therapies are ineffective for the management of cardiometabolic risk in this patient population. Although the knowledge of complex cardiometabolic comorbidities in PLWH continues to expand, significant knowledge gaps remain. Ongoing studies aimed at understanding interorgan communication and energy balance provide insights into metabolic observations in PLWH and reveal potential therapeutic targets. Our review focuses on current knowledge and recent advances in HIV-associated adipose tissue dysfunction, highlights emerging adipokine paradigms, and describes critical mechanistic and clinical insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School at UTHealth, Houston, TX 77030, USA.
ORCID-Profile: Claudia E Ramirez Bustamante, Neeti Agarwal, Aaron R Cox, Sean M Hartig, Jordan E Lake, Ashok Balasubramanyam
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ramirez Bustamante, C. E., Agarwal, N., Cox, A. R., Hartig, S. M., Lake, J. E., & Balasubramanyam, A. (2024). Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV. Endocrine Reviews, 45(2), 190-209. https://doi.org/10.1210/endrev/bnad028
Vancouver
Ramirez Bustamante CE, Agarwal N, Cox AR, Hartig SM, Lake JE, Balasubramanyam A. Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV. Endocrine Reviews. 2024;45(2):190-209. doi:10.1210/endrev/bnad028
BibTeX
@article{RamirezBustamante2024,
author = {Ramirez Bustamante, Claudia E and Agarwal, Neeti and Cox, Aaron R and Hartig, Sean M and Lake, Jordan E and Balasubramanyam, Ashok},
title = {Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV},
journal = {Endocrine Reviews},
year = {2024},
volume = {45},
number = {2},
pages = {190--209},
doi = {10.1210/endrev/bnad028}
}
EUVIMED